Adv Mater

1. ZHU J, Zhu Y, Huang J, Zhang W, et al
   Icing on the Cake: Integrating Optical Fiber with Second Near-Infrared Aggregation-Induced Emission Luminogen for Exceptional Phototheranostics of Bladder Cancer.
   Adv Mater. 2025 May 9:e2502452. doi: 10.1002/adma.202502452.
   

   >> Share

   
   

   
   Arch Esp Urol

2. KHAN AA, Ahluwalia C, Khurana R, Ahuja S, et al
   Evaluation of the EMT Markers SNAIL-SLUG and TWIST in Urothelial Carcinoma of the Bladder: A Retrospective Study.
   Arch Esp Urol. 2025;78:289-295.
   

   >> Share

   
   

   
   Basic Clin Androl

3. SAHIN S, Ulus I, Canitez IO, Yentur S, et al
   The effect of intravesical Bacillus Calmette-Guerin (BCG) treatment on sperm parameters in non-muscle-invasive bladder cancer patients.
   Basic Clin Androl. 2025;35:17.
   

   >> Share

   
   

   
   Biol Sex Differ

4. CHAUDHARY P, Singha B, Abdel-Hafiz HA, Velegraki M, et al
   Sex differences in bladder cancer: understanding biological and clinical implications.
   Biol Sex Differ. 2025;16:31.
   

   >> Share

   
   

   
   BMC Bioinformatics

5. LIOU K, Wang JP
   Integrating genetic and gene expression data in network-based stratification analysis of cancers.
   BMC Bioinformatics. 2025;26:126.
   

   >> Share

   
   

   
   BMC Cancer

6. LAN T, Zhu Y, Zhong W, Tan Q, et al
   Evaluating the efficacy and safety of bladder-sparing regimen with Disitamab Vedotin combined with Toripalimab and pelvic lymph node dissection in muscle-invasive bladder cancer patients: study protocol of a multicenter single-arm phase II trial.
   BMC Cancer. 2025;25:868.
   

   >> Share

   
   

   
   BMC Urol

7. FRASLIN A, Colrat F, Karimi M, Bonastre J, et al
   Characteristics, management and survival outcomes in patients with muscle-invasive bladder cancer at high risk of recurrence in France: a subgroup analysis from the coblance cohort.
   BMC Urol. 2025;25:120.
   

   >> Share

   
   

   
   Brain Behav Immun Health

8. MIKOLASKOVA I, Gidron Y, Durmanova V, Suchankova M, et al
   Mental distress and inflammation in bladder cancer: The nerve makes things less vague.
   Brain Behav Immun Health. 2025;46:100995.
   

   >> Share

   
   

   
   Braz J Med Biol Res

9. MAO X, Yang R, Yan Y, Zeng Y, et al
   Single-cell analysis reveals potential therapeutic markers of peripheral blood mononuclear cells from bladder cancer patients.
   Braz J Med Biol Res. 2025;58:e14002.
   

   >> Share

   
   

   
   Cancer Cell

10. WANG M, Chen X, Tan P, Wang Y, et al
    Acquired semi-squamatization during chemotherapy suggests differentiation as a therapeutic strategy for bladder cancer.
    Cancer Cell. 2025;43:985-987.
    

    >> Share

    
    

    
    Cancer Genet

11. LI W, Yin Q, Qiu Y, Liu J, et al
    Mechanistic study of Liquiritigenin inhibiting bladder cancer cell proliferation and migration by regulating STING1.
    Cancer Genet. 2025;294-295:156-170.
    

    >> Share

    
    

    
    Cancer Lett

12. YANG R, Wang S, Li Z, Yin C, et al
    Patient-derived organoid co-culture systems as next-generation models for bladder cancer stem cell research.
    Cancer Lett. 2025 May 12:217793. doi: 10.1016/j.canlet.2025.217793.
    

    >> Share

    
    

    
    Cancer Med

13. TOMIYAMA E, Fujita K, Matsuzaki K, Narumi R, et al
    EIF2S1 in Urinary Extracellular Vesicles as a Novel Diagnostic Marker for Bladder Cancer.
    Cancer Med. 2025;14:e70964.
    

    >> Share

    
    

    
    Cancer Res Commun

14. ROA FJ, Roubelakis M, Paschidis K, van Creij NCH, et al
    Repurposing amiodarone for bladder cancer treatment.
    Cancer Res Commun. 2025 May 12. doi: 10.1158/2767-9764.CRC-24-0433.
    

    >> Share

    
    

    
    Cancer Res Treat

15. LEE HW, Jung EH, Kim KH, Ha HK, et al
    Real-world Efficacy of Intravesical Gemcitabine for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer.
    Cancer Res Treat. 2025 May 12. doi: 10.4143/crt.2025.
    

    >> Share

    
    

    
    Cancers (Basel)

16. DEL GIUDICE F, Abu-Ghanem Y, Nair R, Mensah E, et al
    Contemporary Trends and Predictors Associated with Adverse Pathological Upstaging Among Non-Metastatic Localized Clinical T2 Muscle-Invasive Bladder Cancers Undergoing Radical Cystectomy: Outcomes from a Single Tertiary Centre in the United Kingdom.
    Cancers (Basel). 2025;17:1477.
    

    >> Share

    
    

    
    Chirurgia (Bucur)

17. RADU CG, Radavoi GD, Aurelian J, Achim IF, et al
    Quality of Life Analysis in Patients with Simple Cutaneous Ureterostomy versus Ileal Conduit Bricker Following Radical Cystectomy.
    Chirurgia (Bucur). 2025;120:205-217.
    

    >> Share

    
    

    
    Clin Genitourin Cancer

18. AL-NADER M, Krafft U, Darr C, Hess J, et al
    Impact of Extended Versus Limited Lymph Node Dissection on Surgical Outcome, Recurrence Patterns and Survival After Radical Cystectomy.
    Clin Genitourin Cancer. 2025;23:102337.
    

    >> Share

    
    
19. GEYNISMAN DM, Chepynoga K, Yates G, Tate A, et al
    Estimating the Impact of Adjuvant Treatment With Nivolumab on Long-Term Survivorship Rates Compared With Surveillance in Muscle Invasive Urothelial Carcinoma: Mixture Cure Modeling Analyses of Disease-Free Survival From the Phase 3 CheckMate 274 Trial
    Clin Genitourin Cancer. 2025;23:102335.
    

    >> Share

    
    
20. MIYAKE M, Nishimura N, Iemura Y, Yoshikawa M, et al
    Impact of Initial Relative Dose Intensity on Tumor Response and Survival Outcomes in Enfortumab Vedotin Monotherapy for Previously Treated Advanced Urothelial Carcinoma: A Real-world Analysis From a Multicenter Study.
    Clin Genitourin Cancer. 2025;23:102326.
    

    >> Share

    
    
21. REESINK DJ, Voskuilen CS, van de Garde EMW, Hendricksen K, et al
    Survival in Responders and Nonresponders of Neoadjuvant and Induction Chemotherapy in Invasive Urothelial Carcinoma of the Urinary Bladder: A Clinical and Pathological Stage-Matched Analysis.
    Clin Genitourin Cancer. 2025;23:102319.
    

    >> Share

    
    

    
    Clin Geriatr Med

22. MACDONALD L, Smith M, Bree KK
    New Paradigms for Bladder Cancer Management in Geriatrics.
    Clin Geriatr Med. 2025;41:175-185.
    

    >> Share

    
    

    
    Comb Chem High Throughput Screen

23. LI XD, Zhu JM, You Q, Wu XH, et al
    Identification of Selected Genes Associated With the Prediction of Prognosis in Bladder Cancer.
    Comb Chem High Throughput Screen. 2025.
    

    >> Share

    
    

    
    Discov Oncol

24. ZHAO K, Xu G, Jin J, Peng C, et al
    Integrated prognostic assessment of apoptosis and chemotherapy related gene in bladder cancer: a prognostic signature.
    Discov Oncol. 2025;16:718.
    

    >> Share

    
    
25. LIU C, Liao C, Sun B, Guo Z, et al
    Tumour-infiltrating immune cells as a novel prognostic model for bladder cancer.
    Discov Oncol. 2025;16:725.
    

    >> Share

    
    

    
    Ecotoxicol Environ Saf

26. WANG N, Song W, Ji J, Guo W, et al
    Metal-organic framework nanomaterials alter cellular metabolism in bladder cancer.
    Ecotoxicol Environ Saf. 2025;298:118292.
    

    >> Share

    
    

    
    Endocrine

27. LIU Y, Jia C, Wang Z, Zhang Y, et al
    Temozolomide as neoadjuvant therapy for bladder paraganglioma.
    Endocrine. 2025;88:431-433.
    

    >> Share

    
    

    
    Eur Urol

28. SUBIELA JD, Scilipoti P, Contieri R, Lobo N, et al
    Management Dilemma for Very High-risk Non-muscle-invasive Bladder Cancer: Real-World Data Challenge the Guideline Recommendation for Upfront Radical Cystectomy.
    Eur Urol. 2025 May 14:S0302-2838(25)00283-0. doi: 10.1016/j.eururo.2025.
    

    >> Share

    
    
29. WARD DG, Bryan RT
    Should We Incorporate Urinary Tumour DNA Status in Treatment Decisions for Patients with Non-muscle-invasive Bladder Cancer?
    Eur Urol. 2025 May 10:S0302-2838(25)00268-4. doi: 10.1016/j.eururo.2025.
    

    >> Share

    
    

    
    Expert Opin Investig Drugs

30. SANTONI M, Rizzo A, Massari F
    Unlocking the mechanisms underlying the activity of pembrolizumab plus enfortumab vedotin in patients with urothelial carcinoma.
    Expert Opin Investig Drugs. 2025;34:259-265.
    

    >> Share

    
    

    
    Front Immunol

31. LUO P, Zheng L, Zou J, Chen T, et al
    Corrigendum: Insights into vitamin A in bladder cancer, lack of attention to gut microbiota?
    Front Immunol. 2025;16:1609154.
    

    >> Share

    
    
32. WANG Y, He M, Li J, Li L, et al
    Immunotherapeutic strategies for invasive bladder cancer: a comprehensive review.
    Front Immunol. 2025;16:1591379.
    

    >> Share

    
    
33. MA Q, Hou S, Ma H, Gao J, et al
    Prognostic significance of circulating tumor DNA in urothelial carcinoma patients undergoing immune checkpoint inhibitor therapy: a systematic review and meta-analysis.
    Front Immunol. 2025;16:1574449.
    

    >> Share

    
    

    
    Front Nutr

34. YE J, Xie Y, Ran B, Han P, et al
    Prognostic impact of nutritional indicators based on Lasso-Cox regression for non-muscle-invasive bladder cancer.
    Front Nutr. 2025;12:1560655.
    

    >> Share

    
    

    
    Front Oncol

35. ZHANG R, Ke CX
    Advances in bladder preservation therapy for muscle-invasive bladder cancer.
    Front Oncol. 2025;15:1562260.
    

    >> Share

    
    

    
    Gene

36. BARIS MOGUL C, Duran MB, Caner V, Turk NS, et al
    The PD-L1 Promoter Methylation Predicts Gene And Protein Expression Levels in Urothelial Carcinoma.
    Gene. 2025;959:149503.
    

    >> Share

    
    

    
    Hereditas

37. LIU H, Ma J, Yan X
    Circ_RPPH1 promotes bladder urothelium carcinoma proliferation and EMT by recruiting and binding to EIF4 A3.
    Hereditas. 2025;162:72.
    

    >> Share

    
    

    
    Hinyokika Kiyo

38. NAKATAKE N, Ueda N, Takezawa K, Kato T, et al
    [A Case of Open Poucholithotomy for Recurrence of Indiana Pouch Stones].
    Hinyokika Kiyo. 2025;71:115-119.
    

    >> Share

    
    
39. IKADAI R, Arase S, Hasegawa Y
    [Nephrogenic Adenoma : A Case Report].
    Hinyokika Kiyo. 2025;71:111-113.
    

    >> Share

    
    

    
    Indian J Cancer

40. NAVRIYA S, Talwar HS, Mittal A, Kumar S, et al
    Evidence versus practice involving universal acceptance of neoadjuvant chemotherapy in muscle-invasive bladder cancer: Results from a tertiary care center in India.
    Indian J Cancer. 2025;62:111-119.
    

    >> Share

    
    

    
    Int J Clin Oncol

41. SAZUKA T, Taoka R, Miki J, Saito R, et al
    Impact of lymph-node dissection during radical cystectomy for non-muscle-invasive bladder cancer: Japanese multicenter retrospective study.
    Int J Clin Oncol. 2025 May 10. doi: 10.1007/s10147-025-02778.
    

    >> Share

    
    

    
    Int J Med Robot

42. WATANABE H, Matsushita Y, Tamura K, Motoyama D, et al
    Robot-Assisted Radical Cystectomy With Intracorporeal Ileal Conduit Using the Hinotori Surgical Robot System: A Single Surgeon's Initial Experience of 20 Cases.
    Int J Med Robot. 2025;21:e70074.
    

    >> Share

    
    

    
    Int J Mol Sci

43. KIM M, Jung E, Song G, Joung J, et al
    Diagnostic and Prognostic Potential of SH3YL1 and NOX4 in Muscle-Invasive Bladder Cancer.
    Int J Mol Sci. 2025;26:3959.
    

    >> Share

    
    

    
    Int J Urol

44. MIYAKE M
    Editorial Comment From Dr. Miyake to Effects of Robot-Assisted Radical Cystectomy on Peritoneal Carcinomatosis and Prognosis in Patients With Muscle-Invasive Bladder Cancer: A Multicenter Retrospective Study.
    Int J Urol. 2025 May 15. doi: 10.1111/iju.70112.
    

    >> Share

    
    

    
    Int Urol Nephrol

45. ZHANG S, Chen C, Mo C, Fan N, et al
    A clinical study of RC48-ADC combined with PD-1 inhibitor in bladder preservation therapy for muscle-invasive bladder cancer (MIBC)-based on real-world data analysis.
    Int Urol Nephrol. 2025 May 14. doi: 10.1007/s11255-025-04567.
    

    >> Share

    
    

    
    J Cancer Surviv

46. DOS REIS PF, Martucci RB
    Factors influencing health-related quality of life in patients with bladder or kidney cancer: a prospective cohort study of the impact of nutritional status and frailty phenotype.
    J Cancer Surviv. 2025;19:743-753.
    

    >> Share

    
    

    
    J Endourol

47. KUMAR S, Mehta R, Sah R
    Letter: Comment on "Enhanced Artificial Intelligence in Bladder Cancer Management: A Comparative Analysis and Optimization Study of Multiple Large Language Models".
    J Endourol. 2025 May 9. doi: 10.1089/end.2025.0277.
    

    >> Share

    
    

    
    J Int Med Res

48. DENG J, Wang G, Yang Y, Liao M, et al
    A rare case report: Bladder endometriosis at the urachus.
    J Int Med Res. 2025;53:3000605251340535.
    

    >> Share

    
    

    
    J Racial Ethn Health Disparities

49. DE ANGELIS M, Baudo A, Siech C, Jannello LMI, et al
    The effect of race/ethnicity on cancer-specific mortality after trimodal therapy.
    J Racial Ethn Health Disparities. 2025;12:1416-1422.
    

    >> Share

    
    

    
    JU Open Plus

50. MULUK SL, Drake C, Sun Z, Bhattacharya M, et al
    Drive Time to Physicians and Outcomes for Bladder Cancer.
    JU Open Plus. 2025;3:e00033.
    

    >> Share

    
    

    
    Kaohsiung J Med Sci

51. WU GF, Luo ZG, Gao K, Ren Y, et al
    LRP8 Regulates Lipid Metabolism to Stimulate Malignant Progression and Cisplatin Resistance in Bladder Cancer.
    Kaohsiung J Med Sci. 2025 May 15:e70042. doi: 10.1002/kjm2.70042.
    

    >> Share

    
    

    
    Lancet Microbe

52. MAKLIN T, Taira A, Arredondo-Alonso S, Shao Y, et al
    Geographical variation in the incidence of colorectal cancer and urinary tract cancer is associated with population exposure to colibactin-producing Escherichia coli.
    Lancet Microbe. 2025;6:101015.
    

    >> Share

    
    

    
    Med Oncol

53. OSKOUIE IM, Amirzargar H, Dezfuli AS, Mashhadi R, et al
    Reducing the effective dosage of Mitomycin C on a high-grade bladder cancer cell line through combination with selenium nanoparticles: An in vitro study.
    Med Oncol. 2025;42:207.
    

    >> Share

    
    

    
    medRxiv

54. CHRYSANTHOPOULOU SA, Hedspeth T, Antinozzi D, Huang AW, et al
    Simulation Models for Bladder Cancer: A Scoping Review.
    medRxiv [Preprint]. 2025 Mar 18:2025.03.17.25324125.
    

    >> Share

    
    

    
    Nat Rev Urol

55. KLUMPER N, Cox A, Sjodahl G, Roghmann F, et al
    Pre-treatment metastatic biopsy: a step towards precision oncology for urothelial cancer.
    Nat Rev Urol. 2025;22:256-267.
    

    >> Share

    
    

    
    Pathol Res Pract

56. LIMA MZT, Bastos DA, Mattedi RL, Dzik C, et al
    Infiltrating Natural Killer cells influence the efficacy of BCG immunotherapy in non-muscle-invasive bladder cancer.
    Pathol Res Pract. 2025;270:155997.
    

    >> Share

    
    

    
    Sci Rep

57. SHI K, Li X, Chen R, Wang Z, et al
    Bousigonine D from Bousigonia mekongensis inhibits bladder cancer growth and overcomes cisplatin resistance.
    Sci Rep. 2025;15:16254.
    

    >> Share

    
    

    
    Transl Androl Urol

58. CHEN Y, Yan Z, Li L, Liang Y, et al
    Identification and validation of a 9-RBPs-related gene signature associated with prognosis and immune infiltration in bladder cancer based on bioinformatics analysis and machine learning.
    Transl Androl Urol. 2025;14:1066-1081.
    

    >> Share

    
    

    
    Urol Oncol

59. GUAN B, Chen S, Tao Z, Jiang Y, et al
    Pattern and risk factors of local recurrence and intravesical recurrence after segmental ureterectomy for upper tract urothelial carcinoma.
    Urol Oncol. 2025;43:330.
    

    >> Share

    
    
60. KUMAR S, Nayyar R, Jain S, Seth A, et al
    Immediate second resection versus restage transurethral resection of bladder tumor: A prospective randomized clinical trial (IMMERSE trial).
    Urol Oncol. 2025;43:331.
    

    >> Share

    
    
61. ZENG E, Saucke M, Rose A, Pati B, et al
    "I was in a very deep, dark place... I wasn't prepared for that": A qualitative assessment of the emotional well-being needs of patients undergoing cystectomy.
    Urol Oncol. 2025;43:328.
    

    >> Share

    
    
62. KIR G, Cecikoglu GE, Aydin A, Yildirim A, et al
    The clinical relevance of cut-off percentage for high-grade urothelial carcinoma within low-grade urothelial carcinoma: A determining factor?
    Urol Oncol. 2025;43:329.
    

    >> Share

    
    
63. SIEFKER-RADTKE AO, Huddart RA, Bilen MA, Balar A, et al
    Bempegaldesleukin plus nivolumab in first-line advanced/metastatic urothelial carcinoma: Results from a phase II single-arm study (PIVOT-10).
    Urol Oncol. 2025;43:330.
    

    >> Share

    
    
64. YASUOKA S, Minegishi T, Kojima S, Okuyama K, et al
    Real-world treatment patterns and outcomes of patients with unresectable or metastatic urothelial carcinoma receiving systemic therapy in Japan.
    Urol Oncol. 2025;43:329.
    

    >> Share

    
    
65. HINOJOSA-GONZALEZ DE, Saffati G, Wahlstedt E, Chaput M, et al
    Oncologic outcomes of pelvic organ-preserving radical cystectomy vs. Standard radical cystectomy: A systematic review and meta-analysis.
    Urol Oncol. 2025;43:275-285.
    

    >> Share

    
    
66. YOUSAF H, Javed A, Sultana N, Farouk K, et al
    Corrigendum to "Unlocking the secrets: Exploring the connection between HPV and bladder cancer in Pakistan" [Urologic Oncology: Seminars and Original Investigations, In Press, Corrected Proof].
    Urol Oncol. 2025 May 14:S1078-1439(25)00171.
    

    >> Share

    
    

    
    Urologiia

67. AZILGAREEVA K R, Morozov A O, Taratkin M S, Gazimiev M A, et al
    [En bloc resection of the large bladder tumors].
    Urologiia. 2025;:136-140.
    

    >> Share

    
    
68. ABOYAN I A, Pakus D I, Pakus S M, Shiranov K A, et al
    [A clinical case of bladder metastasis of skin melanoma].
    Urologiia. 2024;:118-121.
    

    >> Share

    
    

    
    Urology

69. HIGGINS MI, Li J, Ahmed W, Lu C, et al
    Detection Of High-Grade Bladder Cancer In Urine Samples Using In Situ Hybridization Of Long Non-Coding RNA UCA1.
    Urology. 2025 May 13:S0090-4295(25)00468-6. doi: 10.1016/j.urology.2025.
    

    >> Share

    
    

    
    Vet Comp Oncol

70. KUERBITZ EM, Dhawan D, Utturkar S, Sola MF, et al
    Characterisation of Gene Expression in Canine Invasive Urothelial Carcinoma Using a NanoString-Based Urine Assay.
    Vet Comp Oncol. 2025;23:205-215.
    

    >> Share

    
    

    
    World J Urol

71. TAKAHASHI T
    Evaluating the cost-effectiveness and evidence base for perioperative chemotherapy in muscle-invasive bladder cancer.
    World J Urol. 2025;43:310.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share